[Recombinant activated factor VII to control bleeding in cardiovascular surgery: need of efficacy and safety validation].
Blanloeil
Y
Y
Rigal
J C
JC
Bastien
O
O
Carteau
J P
JP
Toussaint-Hacquard
M
M
Lecompte
T
T
D006348:Cardiac Surgical Procedures; D002986:Clinical Trials as Topic; D005167:Factor VII / Q000009:adverse effects / Q000627:therapeutic use*; D006470:Hemorrhage / Q000188:drug therapy*; D006801:Humans; D007431:Intraoperative Complications / Q000188:drug therapy*; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use; D013927:Thrombosis / Q000209:etiology
D011994:Recombinant Proteins; D005167:Factor VII